Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I assume when (in the near future) TL is released the share price will go up. We may well have a market cap of a couple of billion. It’s a possibility we may transition onto the NYSE or back to the NASDAQ and with that comes serious institutional funds and all the questions and DD that is part of that....Having a seat at the top table usually requires experience and reputation. I hope it works out well with the new CFO - I’ve been long for years and remain positive. Picking the top team of a public company is usually based on where you want to see the company go over the next three to five years and not where you are already.
Not at board level she hasn’t and no experience outside of practice......she may turn out to be brilliant and I for one hope she does but I’m just pointing out that without previous experience of being a CFO of any entity (public or private) and of being on the board of any public company then it will be quite a hire if she understands the markets and can show some real teeth around the board room as well as delivering timely and accurate updates. It’s one thing to be a Senior Mgr within a big four accountancy firm but It’s quite another to be the CFO & CIO of a publicly listed company in a bear pit.
It’s good news we have a CFO but she has literally no experience as a CFO running a public company. I’m glad we have hired a CFO however it remains to be seen if she has enough experience, strength of character and independence to improve investor confidence. From an outsider looking at her LinkedIn profile I think she is a perfectly able Finance Manager but that is quite different from a seasoned CFO of a public listed company. Let’s see how the market reacts to this appointment and how public facing she is in terms of profile within the Mgt team.
These guys are paid to post.
https://investorshub.advfn.com/boards/aboutirps.aspx
https://investorshub.advfn.com/boards/IRP_Members.aspx
It’s perfectly okay to post opinions - short or long. It’s perfectly acceptable to invest short or long with your own money. However attempting to persuade others to buy or sell a stock by passing yourself off as an expert with thousands of hours of DD is for me crossing an all important line....opinions and personal choices are fine but he is acting or passing himself off as some kind of insider or market professional and there is no doubt he is very clearly trying to push the shares of WEYL. He even posts photos of himself with Mgt which is either vanity or confirmation of his status.
I think with him acting like this it’s reasonable to draw a couple of conclusions. He is either a
- Walter Mitty Fantasist
- paid external IR consultant / promoter
It could be either but I for one think won’t be investing a single dime on anything he says or predicts. No credibility and I found him curiously amusing as he is rubbish at both anyway.
Every time I see a tweet from Chris about WEYL I burst into laughter....words like “in play” or “bet against me” normally sees the SP drop a few points....one day something he says will be proved correct but until then it’s comedy gold...I hope everyone invested in WEYL goes into the black.....just as I do with all NWBO investors. GL
I agree with you.....
Can you send me across any of your previous posts which were positive about NWBO?
They do manibiotech.....whatever response back from any individual or all the RA’s and the length of time given to each and or all of the RA’s to respond is ultimately a commercial call for Linda after having consulted her SAB.
Some RA’s will move faster than others and some may well respond with detailed feedback while others just acknowledge the plan. Some may not respond at all....it is what it is and nobody outside Mgt knows anything. We have four opportunities at goal.....so will take as long as it takes before LP calls time on this. Waiting any longer will no longer be worth it.
Lots of pressure to get this done already....from patients, from shareholders and a tight financial situation. I felt the takeaway message from the 10Q is that this process is already well underway and must have moved on considerably since the end of Q3. I don’t see this running for many more weeks....just my take on it GL
Troc.....I would be very cautious of what you read on this board...DI is a professional guy. He would never compromise himself by giving anything away that was material and inside. People hear things what they want to hear.....it’s often a grey area but my experience of DI is he gives nothing away that is materially relevant and not in the public domain. GL
https://www.linkedin.com/company/advent-bioservices
Now has 14 staff registered on LinkedIn which is up from 6 staff in total last December.
This captures the mood of British Military Humour and the respect that comes with it...I served myself for six years but experienced nothing like the horrors of the First World War.
I’ve read some posts in my time but the views you express are quite literally beyond ridiculous. Getting a drug from an idea, to trial and to market as a small cap bio start up is hard enough...having to understand how immunotherapy works over time is a learning curve and every shareholder has been forced to go on this learning journey....I won’t even go into detail how the share price has played out over this prolonged time as everyone is well aware...PhaseV, Adam F, market makers etc. None of this makes any difference to me at this point as we are so close. You are entitled to your opinions and to express them constantly day in day out over and over again but I believe your views are one sided, ridiculous and are based on nothing other than finding something to fit a narrative and viewpoint.
Happy 67th Birthday Dad! Go Dad!
— Kristyn Power, CFA (@KristynPower) October 26, 2019
Big thanks to NWBO for another birthday!!!#GBM #Glioblastoma $NWBO pic.twitter.com/neUpMQm17f
Very good! ??????
Tryn2 - it was quite obviously (or so I thought) a joke back to Scotty as he was banging on about Duffy taking over from Linda which is just Scotty stirring the pot here on ihub.
For the record - it was a wind up. I’m shocked people even consider what I said as remotely credible....I literally made up the most ridiculous thing I could think of in an attempt to counter Scotty with an equally ridiculous post.....
We Brits use Irony when poking fun! Apologies to anyone who choked on their cornflakes this morning.
Marzan....I think your second sentence is quite accurate....I don’t want a blue on blue incident on ihub!
I have not given that much thought to your post but I do think a lot about the news on the inter web that Linda is in the running for a senior board position at Merck....I guess it’s likely the game plan is to persuade the board at Merck to bid a small sum for nwbo (and so shareholders get stiffed) but then for her to collect a $25b finders fee.....for brokering the deal. If that did happen I would be really disappointed in her.
Who says Pharma is not taking NWBO seriously? I think this is nonsense...
I do think plenty understand what can be of this which is why we are seeing such an effort to hold it down...now I’m not arguing the investment community may well have taken a bet on this which is not positive and maybe some decisions made by Mgt can be interpreted as poor but anyone with any scientific mind realises the potential......when you allow for more recent learnings. Whatever is going on it’s very clear that those that understand and need to understand I.e the regulatory authorities are all still on board.
It’s very reassuring to see such an influential expert in biotech investing reaching out to good journalists re NWBO
Very well said such idiots on #ihub took me a long time to learn that lesson. You’re a good journalist honestly. But I will say I disagree with you’re standing on $NWBO hopefully data speaks in near term. #biotech #investing not easy
— Chris LaCoursiere (@ChrisLaCoursie1) September 10, 2019
I presume that means the inspection had already occurred before Aug 7th....they have to be speaking about DCVax right?
Interesting find from cognates Aug 7th update - note the sentence about the FDA pre approval inspection preparation
About Cognate BioServices
Cognate is a results-driven contract development and manufacturing organization (CDMO) specializing in cell and cell-mediated gene therapy products. Since 2002, Cognate has serviced autologous and allogeneic products in various stages of development from preclinical to Phase 3, and most recently in pivotal Phase 3 with FDA pre-approval inspection preparation. With development and manufacturing at our core, Cognate made significant investments in infrastructure and quality systems; and we have developed a broad range of commercialization services that facilitate logistics, supply chain planning, and capacity planning to bridge clinical to commercial manufacturing. Cognate provides and develops commercially scalable solutions so that our clients are able to offer safe and high-quality products to as many patients as possible. Please visit www.cognatebioservices.com to find out more about us.
I agree....things are looking positive. I would be very happy to see a more proactive approach with regards to communications as they build up to unblinding...new appointments, trials, manufacturing status update etc
I wish to see tangible signs of an upward momentum in the stock fuelled by lots of small pieces of good news which individually do nothing for the SP but as a collective create confidence and interest...GL
Chris makes claims and statements as though he is an insider. He has no insider information and is a serial fantasist...I’m quite sure he means well and is probably a nice guy outside of investing but to anyone who has experienced him on ihub/Twitter with NWBO or WEYL they quickly conclude that he is unable to separate fact from fiction and writes as though he is some kind of expert.....to any newbie please don’t invest off the back of anything this clown spews out on social media....
So far almost everything he has said or claimed has turned out to be incorrect.....if you make 100 claims about a stock then just by the law of averages you will be correct at least once....eventually.
Sold.....lol
I just love the smell of burning shorts in the morning....
Put some big players together in a room and I’m quite sure he can conduct an orchestra!
Dave is a good hire.....any communications or info flow come from the top....I’m quite sure DI played a role in helping get NW’s stock sale off our backs...
This move is very significant indeed....it’s the first time I’ve seen actual evidence of BP acknowledging the potential of DCVAX
you don’t leave a well paid comfortable job with Merck to join a small biotech with no income and as yet no approvals unless you truly understand the science and can see which way the wind is blowing....very smart hire by NWBO.
Well what’s the full cost of a phase three double blinded placebo controlled trial....over 10 years? There is a reason why tiny little biotechs rarely succeed...the odds are stacked against them and are obviously easy pickings for any kind of stock play. We are lucky that the intellectual property is all owned by NWBO. Cognate will do well and they should as without them the story is likely to have an unhappy ending for shareholders in NWBO.....we are chasing down the last few yards of a marathon journey and NWBO have all but delivered a completed phase three trial while remaining independent and with no income.....so it’s fingers crossed for very good topline data. Long suffering longs should get a great return on their hard-earned money that went into building a gold standard phase three clinical trial. I’m sure you will join me in wanting a successful conclusion for the benefit of patients, shareholders and stakeholders alike.
He explains his investing record on YouTube
Cognate is part of a wider investment from Korea...via medivate
http://www.medivatepartners.com/en/html/current.html
Apologies if this has already been posted but I like reading that Cognate is considered Global number one in commercial scale manufacturing of cell therapies. Read the bio on Cognate contained in the link above. This adds to the overall commercialisation of DCVax.
It’s worth remembering also the investment in cognate includes a sovereign wealth fund.
https://www.businesswire.com/news/home/20180220006077/en/Cognate-Completes-Management-Buyout-Raises-Growth-Capital
Another tragic story...this young man did survive several years though -
http://www.ladbible.com/news/animals-dog-dies-just-15-minutes-after-owner-passes-away-from-cancer-20190820
Exactly...We should all ignore anything Adam F writes about NWBO, his obvious bias and blinkered views has long been discredited...it’s up to Mgt to step up and deliver a response if they feel it’s incorrect and needs correcting.
For what it’s worth, my opinion is it’s a very selective hit piece using some of the facts to write a very one sided viewpoint and so it’s to be taken with a very large pinch of salt.
I’ve not posted here before and I’ve zero stock in WEYL....although I did have a small stake but sold months ago.
WEYL may well turn a buck or two if the various stars align but this is no basis for investing....more luck than anything else.
Some on here live in a Walter Mitty fantasy world radiating confidence and pretending they have some inside relationship with Mgt.....they don’t and they really don’t.
WEYL could well end up at a higher share price than today....but it could also just as easy fall foul of lots of hurdles on the way. It’s about as much of a gamble as you could imagine...
If you need to shout about the size of your position on this board like md1225 does then everyone should realise that this is about as risky as playing poker with a room full of triads...
My advice.....if you like prospecting for gold in the Far East and can manage a total wipe out without loosing your shirt/home/pension fund then good luck to you...but if you are even slightly concerned I’d get out fast and try your luck in Las Vegas
I do read Chris Le C posts on WEYL......I don’t want anyone to make a loss or suffer but reading these posts is comedy gold.
Your gut feeling is born out of extreme hunger for news and anxiety.....I believe you are not alone.
I can only say this - the raise was small and is keeping the lights on. They have no real cash coming in so its essential they do it and I prefer very small raises keeping any dilution to a minimum....the amount raised is maybe 4-6 weeks money. That says a lot to me.....some are accusing LP’s et al of committing all kinds of skullduggery but that is in my opinion either someone with a questionable motive or a genuinely distressed long term shareholder that’s been battered and bruised by the whole experience of owning NWBO stock. This raise makes sense if the alternative is running out of cash.
No idea if the SAP has been submitted but it makes a lot of sense to me that they keep that to themselves as it creates a timeline which until the RA’s respond is outside of their control. In my opinion I think meaningful news will come between September and November.
This is interesting....
We're thrilled to announce today our new £3.5 million investment to fund global brain tumour research! With your support, we are funding new projects to discover treatments and improve life today. #ACureCantWait Read more about our new grants here... https://t.co/QuCvWAW0Iu
— The Brain Tumour Charity (@BrainTumourOrg) June 13, 2019